Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Original Studies

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria

Resch, Bernhard MD, PhD*,†; Sommer, Constanze MD; Nuijten, Mark J. C. MD, PhD; Seidinger, Susanne DVM§; Walter, Evelyn PhD; Schoellbauer, Vera MA; Mueller, Wilhelm D. MD, PhD

Author Information
The Pediatric Infectious Disease Journal: January 2012 - Volume 31 - Issue 1 - p e1-e8
doi: 10.1097/INF.0b013e318235455b
  • Buy

Abstract

© 2012 Lippincott Williams & Wilkins, Inc.